References
Cheng J, Luo X, Huang Z, Chen L (2019) Apelin/APJ system: a potential therapeutic target for endothelial dysfunction-related diseases. J Cell Physiol 234:12149–12160
Huang Z, He L, Chen Z, Chen L (2018) Targeting drugs to APJ receptor: from signaling to pathophysiological effects. J Cell Physiol 234:61–74
Kuba K, Sato T, Imai Y, Yamaguchi T (2019) Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology. Peptides 111:62–70
Luo H, Han L, Xu J (2019) Apelin/APJ system: a novel promising target for neurodegenerative diseases. J Cell Physiol 235:638–657
Tatemoto K, Hosoya M, Habata Y et al (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251:471–476
Wysocka MB, Pietraszek-Gremplewicz K, Nowak D (2018) The role of apelin in cardiovascular diseases, obesity and cancer. Front Physiol 9:1–15
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Podgórska, M., Pietraszek-Gremplewicz, K., Nowak, D. (2020). Apelin. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_10036-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-21573-6_10036-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21573-6
Online ISBN: 978-3-030-21573-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences